1-6 of 6
Kristina Schilling
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study

Clinical Trials & Observations
Andreas Tiede, Robert Klamroth, Rüdiger E. Scharf, Ralf U. Trappe, Katharina Holstein, Angela Huth-Kühne, Saskia Gottstein, Ulrich Geisen, Joachim Schenk, Ute Scholz, Kristina Schilling, Peter Neumeister, Wolfgang Miesbach, Daniela Manner, Richard Greil, Charis von Auer, Manuela Krause, Klaus Leimkühler, Ulrich Kalus, Jan-Malte Blumtritt, Sonja Werwitzke, Eva Budde, Armin Koch, Paul Knöbl
Journal: Blood
Blood (2015) 125 (7): 1091–1097.
https://doi.org/10.1182/blood-2014-07-587089
Published: 2015
Includes: Supplemental data
Journal Articles

Safety and Efficacy of the mTOR Inhibitor Everolimus as Early Interventional Replacement for Calcineurin Inhibitors In Graft-Versus-Host Disease (GvHD) Prophylaxis After Allogeneic Stem Cell Transplantation

Herbert G. Sayer, MD, Anne Klink, Thomas Schenk, MD, Anne Treschl, MD, Kristina Schilling, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2010) 116 (21): 2325.
https://doi.org/10.1182/blood.V116.21.2325.2325
Published: 2010
Journal Articles

Analysis of a New graft–versus-host Disease (GvHD) Prophylaxis Regimen with Additional Enteric-coated Mycophenolate Sodium (EC-MPS) Starting 10 Days after Unrelated Allogeneic Stem Cell Transplantation.

Herbert G. Sayer, Lars-Olof Mügge, Sebastian Scholl, Anne Klink, Kristina Schilling, Klaus Höffken
Journal: Blood
Blood (2008) 112 (11): 2202.
https://doi.org/10.1182/blood.V112.11.2202.2202
Published: 2008
Journal Articles

High Overall Response Rate in Calcineurin Inhibitor-Free Treatment with the mTOR Inhibitor Everolimus in Advanced Extensive Chronic GvHD after Allogeneic Stem Cell Transplantation.

Anne Klink, Kristina Schilling, Katrin Rapp, Klaus Höffken, Herbert G. Sayer
Journal: Blood
Blood (2008) 112 (11): 2210.
https://doi.org/10.1182/blood.V112.11.2210.2210
Published: 2008
Journal Articles

Long-Term Survival after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation in AML-Patients Is Consistently Sustained and Influenced by Donor Type Selection.

Herbert G. Sayer, MD, Lars-Olof Muegge, MD, Sebastian Scholl, MD, Kristina Schilling, MD, Anne Klink, Volker Schmidt, Klaus Hoeffken, MD
Journal: Blood
Blood (2007) 110 (11): 5087.
https://doi.org/10.1182/blood.V110.11.5087.5087
Published: 2007
Journal Articles

First Report of a Prospective Randomised Controlled Trial of Recombinant Human Erythropoietin after Allogeneic Blood Stem Cell Transplantation.

Anne Klink, Christoph Kasper, M.D., Sebastian Scholl, M.D., Lars-Olof Muegge, M.D., Kristina Schilling, Anja Markusch, Klaus Hoeffken, M.D., Herbert G. Sayer, M.D.
Journal: Blood
Blood (2004) 104 (11): 1833.
https://doi.org/10.1182/blood.V104.11.1833.1833
Published: 2004